Condition: Atrial Fibrillation (Prevention of Stroke) · Stroke · Sponsor: Medical University Innsbruck
The Austrian Digital Heart Study is a population-based, siteless, randomized, controlled digital trial testing whether a smartphone-based atrial fibrillation screening and management pathway reduces stroke hospitalizations compared with usual care. Adults aged 65 years or older in Austria are randomized to either a digital intervention using the 'Pulskontrolle' app or to usual care. The intervention includes smartphone-camera photoplethysmography for atrial fibrillation screening, confirmatory 7-day ECG patch monitoring in case of suspected atrial fibrillation, and digital education and management support. The primary outcome is hospitalization for stroke of any type within 48 months.
This description comes directly from the study's public registry record.
Sebastian J Reinstadler, MD, PhD · +4351250425621 · sebastian-johannes.reinstadler@i-med.ac.at
Michael Schreinlechner, MD · Michael.Schreinlechner@i-med.ac.at
Always discuss trial participation with your own doctor first.
| Department of Internal Medicine III, Medical University Innsbruck | Innsbruck, Tyrol, Austria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07684053